The Latest Cardiac and Vascular News
Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has signed a distribution agreement with FJ […]
SAN FRANCISCO, Aug. 31, 2023 /PRNewswire/ — RhythmScience, a leader in cardiac data management and services, today announced the formation of its Medical Advisory Board (MAB). Comprised of renowned experts across heart failure and rhythm management, the MAB will provide invaluable clinical guidance and strategic insights to further advance RhythmScience’s mission of […]
HANGZHOU, China, Aug. 30, 2023 /PRNewswire/ — Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as “Zylox-Tonbridge” or the “Company”) announced that its ZENFlow Tiger™ LD PTA Dilatation Catheter (hereinafter referred to as “ZENFlow Tiger™”), a product independently developed by the Company, has received marketing approval from ANVISA. The Company expects […]
SILVER SPRING, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced the publication of a case report highlighting results that demonstrate the potential benefits […]
SHENZHEN, China , Aug. 30, 2023 /PRNewswire/ — LifeTech Scientific Corporation (the “Company” or “Lifetech”), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the “Group”) for the six months ended 30 June 2023 (the “Reporting […]
AMSTERDAM, Aug. 30, 2023 /PRNewswire/ — The latest study indicates that adding TCM Qili Qiangxin Capsules (developed and produced by Yiling Pharmaceutical) to the standard of care for heart failure can significantly reduce the risk of re-hospitalization due to worsening heart failure and cardiovascular death in patients with chronic heart failure. On August […]
NEW YORK, Aug. 30, 2023 /PRNewswire/ — Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) to prevent heart attacks, strokes and deaths due to blood clots in patients with certain rare medical conditions, today announced the expanded evaluation of tecarfarin for the treatment […]
CAMBRIDGE, Mass., Aug. 30, 2023 /PRNewswire/ — Concert AI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced today that its Eureka Clinical AI platform’s Cardio Suite now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to help identify, treat, and manage cardiovascular disease. Eureka Clinical AI […]
AACHEN, Germany–(BUSINESS WIRE)–Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the appointment of Professor J Mocco MD, MS, FAANS, FAHA of Icahn School of Medicine at Mount Sinai, NY, USA as an independent member of their Board of Directors. “I am delighted to welcome Professor Mocco […]
TEL AVIV, Israel–(BUSINESS WIRE)–Radiaction Medical, LTD (“Radiaction”), a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today made two announcements. First, it has raised $12.6 million in Series C2 funding led by U.S. private equity fund InnovaHealth Partners with participation from additional co-investors. […]
